Interpreting the Economic Value of Docetaxel, Platinum, and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The Importance of Decision Context, Utility Timing, and Treatment Burden

Value in Health · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles